Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 3
1965 1
1967 1
1969 2
1971 1
1974 1
1976 1
1977 1
1978 2
1983 1
1984 1
1986 1
1992 1
1993 1
1995 2
2000 2
2001 1
2002 3
2003 4
2004 7
2005 12
2006 9
2007 23
2008 11
2009 15
2010 34
2011 29
2012 29
2013 37
2014 28
2015 21
2016 18
2017 16
2018 23
2019 24
2020 27
2021 38
2022 23
Text availability
Article attribute
Article type
Publication date

Search Results

394 results
Results by year
Filters applied: . Clear all
Page 1
A Phase 1/2 Study of Lazertinib 240 mg in Patients With Advanced EGFR T790M-Positive NSCLC After Previous EGFR Tyrosine Kinase Inhibitors.
Cho BC, Han JY, Kim SW, Lee KH, Cho EK, Lee YG, Kim DW, Kim JH, Lee GW, Lee JS, Shim BY, Kim JS, Chun SH, Lee SS, Kim HR, Hong MH, Ahn JS, Sun JM, Lee Y, Lee DH, Kang JA, Lee N, Kwon MJ, Espenschied C, Yablonovitch A, Ahn MJ. Cho BC, et al. Among authors: shim by. J Thorac Oncol. 2022 Apr;17(4):558-567. doi: 10.1016/j.jtho.2021.11.025. Epub 2021 Dec 24. J Thorac Oncol. 2022. PMID: 34958928 Free article. Clinical Trial.
Acupuncture in accomplishing 'health for all'.
Yin CS, Shim BS, Lee H, Choi SH. Yin CS, et al. Among authors: shim bs. Neurol Res. 2010 Feb;32 Suppl 1:18-21. doi: 10.1179/016164109X12537002793724. Neurol Res. 2010. PMID: 20034439 Review.
394 results